Page 2 - Value Acquisition News Today

More momentum for SPACs with Pre-Deal SPACs creeping towards NAV and SPACs surging near vote dates. Todays three mergers are trading well.

Wednesday was another positive day for SPACs despite the two announced deals being initially down. Spartacus Acquisition (TMTS) is taking NextNav public in a $900m deal. And, another 3 deal votes today.

The improving narrative is supported by stable, positive market dynamics. Dont be surprised to see retail and others getting back into SPACs if the market continues this way.

Chamath Files 4 New Biotech SPACs Todays SPAC highlight came post market as Chamath dropped four new SPAC S-1s for $800M total. JWS vote passes, with TSIA and JIH set to vote tomorrow. Author: In another win on Day-1 of new De-SPAC ticker trading, BARK, which just closed its merger with Northern Star Acquisition Co. (STIC) rose nearly 7%. One more example of a recent De-SPAC that has traded up shortly after, following SOFI early this week and others last month. Investors will be sure to watch ...

June will be a busy month of SPAC deal votes and, likely, little other activity. But, could the narrative change if de-SPAC performance outperforms expectations?

SPAC IPOs Mixed, DCRN Deal Slightly Rises, IPOE/SoFi Up Next IPOE fell ahead of its vote tomorrow, while DCRN rose slightly on its deal with Tritium. Of todays SPAC IPOs: 1 rose, and 2 fell. Author: This morning Decarbonization Plus II (DCRN) announced a deal to take Tritium, an Australian EV charge company, public in a $1.4B SPAC deal. The deal has no PIPE and they currently have $403M in trust. The market was, somewhat, pleased with the deal as DCRN rose modestly +1.4%, though it still trade...

References in this Quarterly Report on Form 10-Q to the Company, our, us or we refer to Starboard Value Acquisition Corp. The following discussion and analysis of the Companys financial condition... | May 26, 2021

To embed, copy and paste the code into your website or blog: Dealmaking within the PMB sector enjoyed an impressive start as companies across the globe embarked on their post-pandemic recovery The global pharma, medical and biotech (PMB) sector saw US$95.4 billion in deal activity over the first quarter, almost three times the US$33 billion in deals announced in Q1 2020. Deal volume, meanwhile, increased 28% year on year, with 466 deals announced. [embedded content] This strong activity is carr...

SPACs Could Use Some Good News The SPAC markets correction is starting to feel very painful for those that bought during "peak SPAC." The next deals and de-SPACs will be watched closely. Author: Apr 21, 2021 Tuesday was a painful day for the whole market, but SPAC investors were hit especially hard as there seemed nowhere to hide. 20 SPACs were down over 3%, RICE, THCB, STPK, RSVA, NGA, FSRV, CCIV, and STIC were all down over over 5.5%, and there are now 244 pre-deal SPACs trading under $10. ...

Author Bio A member of The Motley Fool since 2006, Scott began contributing content in 2013. His focus includes renewable energy, gold, and water utilities. Follow him on Twitter. . . Follow @scott81236 With 407 companies debuting on the public markets, there was certainly no shortage of IPOs to keep track of last year. Nearly as many as the 409 companies that went public in 2018 and 2019 combined, the number of IPOs in 2020 was the highest since 2000, when 429 companie...